When switching, youll typically start tirzepatide after your last dose of semaglutide
Patients should contact their healthcare provider if they experience: Signs of infection at injection sites , including increasing warmth, redness spreading beyond the immediate injection area, purulent drainage, or fever
The limit of quantitation (LOQ) for all SCCAs was at 3.3 times the Lowest limit of detection (LLOD) (s/n) 33 following recommended values for chromatographic validation of metabolites [14]
The information of antibodies used was listed below: CPT1A (Cat# 66039-1-Ig, Proteintech), p-AMPK (Cat# 2535, Cell Signaling Technology), S6K (Cat# 66638-1-Ig, Proteintech), p-S6K (Cat# 28735-1-AP, Proteintech), S6 (Cat# 66886-1-Ig, Proteintech), p-S6 (Cat# 29223-1-AP, Proteintech), GAPDH (Cat# GB15004-100, Servicebio)